Duration of Current Alopecia Areata Episode Predicts the Effectiveness of Baricitinib in Japanese Patients: A Single-Center Retrospective Study

This study assessed the effectiveness of baricitinib in 27 Japanese patients with alopecia areata (AA) over one year, finding that 58% achieved a SALT score ≤20 by 12 months. It highlighted that shorter AA episodes (<4 years) predict better treatment outcomes, with 66.7% of patients experiencing hair regrowth after 12 months. The study underscores the importance of early intervention, as earlier treatment initiation may enhance clinical benefits and prevent chronic progression. Adverse events were mild, and no patients discontinued treatment, suggesting baricitinib's tolerability for long-term use. However, the small sample size and focus on severe AA may limit the findings' applicability to milder cases.